Skip to content
About
R&D
News/Media
Ethics
Support
About
R&D
News/Media
Ethics
Support
Company Overview
Milestones
Directions
Company Overview
Milestones
Directions
Pipeline
Publications
BiomeTreasure
Pipeline
Publications
BiomeTreasure
Press Releases
Media
Press Releases
Media
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Announcements
Contact Us
Announcements
Contact Us
EN
KR
CN
EN
KR
CN
Posted on
2025년 12월 04일
By
atogen_usr
In
보도자료
Facebook
Twitter
LinkedIn
에이투젠, 자체개발 혈당유산균 제품으로 IR52 장영실상 수상
Previous
에이투젠, 체지방 감소 프로바이오틱스 식약처 개별인정 획득
Next
atogen_usr
Recommended Posts
에이투젠, 다이어트 유산균 ‘리씬 365’ 출시… 기능성 유산균 라인업 확대
에이투젠, 장내 미생물 활용 여성 질환 솔루션 제공
에이투젠, 체지방 감소 프로바이오틱스 식약처 개별인정 획득
에이투젠, 자체개발 혈당유산균 제품으로 IR52 장영실상 수상
About
Company Overview
Milestones
Directions
R&D
Pipeline
Overview
Therapeutics
Overview
Bacterial Vaginosis
Oncology
Allergic Diseases
Inflammatory Diseases
MASH
Functional Probiotics
Overview
Postprandial Blood Glucose Control
Body Fat Reduction
Muscle Function & Strength
Immune Health
Women’s Vaginal Health
Respiratory Health Support
Publications
BiomeTreasure
News/Media
Press Releases
Media
Ethics
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Support
Announcements
Contact Us
About
Company Overview
Milestones
Directions
R&D
Pipeline
Overview
Therapeutics
Overview
Bacterial Vaginosis
Oncology
Allergic Diseases
Inflammatory Diseases
MASH
Functional Probiotics
Overview
Postprandial Blood Glucose Control
Body Fat Reduction
Muscle Function & Strength
Immune Health
Women’s Vaginal Health
Respiratory Health Support
Publications
BiomeTreasure
News/Media
Press Releases
Media
Ethics
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Support
Announcements
Contact Us